MTOR and breast carcinoma: Phosphoinositide 3-kinase (PI3K)/protein kinase (AKT)/mammalian target of rapamycin (mTOR) signaling pathway, referred to as PI3K/AKT pathway, is one of the most frequently activated pathogenic signaling cascades in breast cancer (16).